Martin Edwards insider trades

Open-market stock purchases and sales by Martin Edwards, Director at Verona Pharma plc, from SEC Form 4 filings since Jun 26, 2019.

Recent trades

DateStockTradeValue
Oct 7, 2025VRNA Verona Pharma plcSold (not open market)—
Oct 7, 2025VRNA Verona Pharma plcSold (not open market)—
Oct 7, 2025VRNA Verona Pharma plcSold (not open market)$256K
Oct 7, 2025VRNA Verona Pharma plcSold (not open market)$464K
Oct 7, 2025VRNA Verona Pharma plcSold (not open market)$49.6K
Oct 7, 2025VRNA Verona Pharma plcBought (not open market)—
Oct 7, 2025VRNA Verona Pharma plcSold (not open market)$101K

Companies traded

  • VRNA Verona Pharma plc: 1 buy, 3 sales, last Oct 7, 2025
  • MORF Morphic Holding, Inc: 1 buy, last Aug 16, 2024
  • INZY Inozyme Pharma, Inc: other filings, last Jun 18, 2024
  • RETA Reata Pharmaceuticals Inc: other filings, last Sep 26, 2023
  • KALV KalVista Pharmaceuticals, Inc: other filings, last Sep 30, 2021

Get free alerts when Martin Edwards files a new trade →